Elpiscience
Leading the innovation and development of the next generation of cancer immunotherapies
Hyfinity Investments are led by senior partners from top-tier investment institutions in China, with years of
experiences in healthcare investment, local operation, and overseas licensing. Hyfinity Investments devote
to advance the global innovations in partnerships with high unmet needs and rich clinical resources
in China. The mission is to foster industry leaders through converging resources globally.
Leading the innovation and development of the next generation of cancer immunotherapies
Leading biotech in the field of regenerative medicine and cell therapy
Leading healthcare big data and AI company. With most advanced NLP and AI technique, the Compay provides precision medicine solutions combined with clinical data and gene data.
Leading metabolomics company integrating most innovative proprietary clinical IVD products，healthcare solutions and research services
YunMed focuses on application of high-performance polymers in advanced medical devices by building strong know-how through the entire value chain involving polymer production, thermal forming and additive manufacturing.
The Company provides leading and bacterial diseases solutions with extensive phage research and development experiences.
With innovative materials technology platform, New Value provides proprietary solutions on hemostasis, wound treatment and skin care.
Global leader in Robotic assisted MIS
Engages in R&D, production and sales for dressing, surgical instruments, and medical daily care products
Leading novel bio-regenerative material company
Digital orthopedic navigational & surgical equipment company
Leading ctDNA detection service provider in China
Leading genomic sequencing service provider in China
Manufacturer of high value orthopedics consumables in China, including spinal, trauma, joint, and ankle
Improved formulation biotech in the US for oral testosterone delivery
Leader in the field of regenerative medicine and oral treatment biological materials
The largest private mental hospital group in China which owns the only private TierIIIA mental hospital in China
The largest children and women hospital group in China providing premium quality comprehensive medical services to mid and high end families
Innovative PBM enterprise based on real world clinical prescription data in China
Leading domestic pharmaceutical marketing and distribution enterprise
Leading biotech in the field of cell therapy, stem cell and gene editing
Leading manufacturer of renal dialysis consumables in China
Leading domestic implanted medical device platform with marketed brain pacemaker product
Leading IVD products manufacturer in China
Largest CMO company in China
Leading biopharmaceutical enterprise with blockbuster antibody drug marketed in China
Leading chemiluminescent diagnostic device and reagent manufacturer in China
The leading flat panel detector company in China
Leading domestic eye hospital group
Leading integrated hospital information system provider in China
The global leading company for protein degradation
leading innovative HSV-2 oncolytic virus products
innovative drug company targeting gpcr for nash
innovative company with oncolytic virus and self-replicating RNA two platforms
leading a new generation of cytokine activation platform
Golden Age for Healthcare Investment
Combing high unmet needs and rich clinical resources in China with Global Technologies
Platform resources from regulatory, hospital to industry
Cross border experiences for product Licensing and partnering
Focused Investment
Exclusive Sector Coverage
Heavy Commitment on portfolio
Join UsAs a member of the leading healthcare investment institution building industry leaders